{"id":1085860,"date":"2023-01-06T11:10:21","date_gmt":"2023-01-06T16:10:21","guid":{"rendered":"https:\/\/bugaluu.com\/news\/fda-approves-new-drug-lecanemab-that-appears-to-slow-early-mild-alzheimers\/1085860\/"},"modified":"2023-01-06T11:10:21","modified_gmt":"2023-01-06T16:10:21","slug":"fda-approves-new-drug-lecanemab-that-appears-to-slow-early-mild-alzheimers","status":"publish","type":"post","link":"https:\/\/bugaluu.com\/news\/fda-approves-new-drug-lecanemab-that-appears-to-slow-early-mild-alzheimers\/1085860\/","title":{"rendered":"FDA approves new drug lecanemab that appears to slow early, mild Alzheimer&#8217;s"},"content":{"rendered":"<p>Federal drug regulators on Friday approved\u00a0lecanemab, sold under the brand name Leqembi, an Alzheimer&#8217;s drug that appears to slow the disease.<\/p>\n<div>\n\u00a0\u00a0\u00a0\u00a0\u00a0<\/div>\n<p>From:<a href=\"http:\/\/rssfeeds.usatoday.com\/~\/723650358\/0\/usatoday-newstopstories~FDA-approves-new-drug-lecanemab-that-appears-to-slow-early-mild-Alzheimers\/\" target=\"_blank\" title=\"FDA approves new drug lecanemab that appears to slow early, mild Alzheimer's\" rel=\"noopener\">USA TODAY &#8211; All Top Headlines<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Federal drug regulators on Friday approved\u00a0lecanemab, sold under the brand name Leqembi, an Alzheimer&#8217;s drug that appears to slow the disease. \u00a0\u00a0\u00a0\u00a0\u00a0 From:USA TODAY &#8211;&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[1],"tags":[],"class_list":["post-1085860","post","type-post","status-publish","format-standard","hentry","category-news","wpcat-1-id"],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pbimBl-4ytS","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/bugaluu.com\/news\/wp-json\/wp\/v2\/posts\/1085860","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bugaluu.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bugaluu.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bugaluu.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bugaluu.com\/news\/wp-json\/wp\/v2\/comments?post=1085860"}],"version-history":[{"count":0,"href":"https:\/\/bugaluu.com\/news\/wp-json\/wp\/v2\/posts\/1085860\/revisions"}],"wp:attachment":[{"href":"https:\/\/bugaluu.com\/news\/wp-json\/wp\/v2\/media?parent=1085860"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bugaluu.com\/news\/wp-json\/wp\/v2\/categories?post=1085860"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bugaluu.com\/news\/wp-json\/wp\/v2\/tags?post=1085860"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}